Momen SE, et al. – This study involved an appraisal of the TNF antagonist induced lupus, targeting the diagnostic criteria, dermatological manifestations, management and outcome. It presented a good prognosis. It was suggested that the treatment ought to customized to each individual case. As cutaneous features were found to be the most common manifestation, the dermatologists were required to be aware of the American college of rheumatology (ACR) diagnostic criteria of lupus. This facilitated accurate diagnoses of TNF antagonist induced lupus.